A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence - Top-Institutions - MDSpire

A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence

  • By

  • Jonathan I. Silverberg

  • Alan D. Irvine

  • Peter Foley

  • James Del Rosso

  • Luis Puig

  • Linda Stein Gold

  • Masahiro Kamata

  • Andreas Wollenberg

  • H. Chih-ho Hong

  • Chia-Yu Chu

  • Yousef Binamer

  • Martin Dossenbach

  • Marta Casillas

  • Gaia Gallo

  • Buelent Akmaz

  • Kim Rand

  • Raj Chovatiya

  • June 17, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Dermatology

  • #2

    Oregon Health & Science University
    Oregon Health & Science University

    Portland, OR

    Key Differentiators

    • Dermatology

Original Source(s)

A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence

  • by Jonathan I. Silverberg, Alan D. Irvine, Peter Foley, James Del Rosso, Luis Puig, Linda Stein Gold, Masahiro Kamata, Andreas Wollenberg, H. Chih-ho Hong, Chia-Yu Chu, Yousef Binamer, Martin Dossenbach, Marta Casillas, Gaia Gallo, Buelent Akmaz, Kim Rand, Raj Chovatiya

  • June 17, 2026

Related Content

Integrating anisotropic heat flow and transformer encoders in convolutional neural network for skin cancer classification

Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice Experiment

FDA OKs first new sunscreen ingredient in more than 25 years